KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Preferred Stock Liabilities (2023 - 2025)

Historic Preferred Stock Liabilities for Evolent Health (EVH) over the last 4 years, with Q2 2025 value amounting to $228.8 million.

  • Evolent Health's Preferred Stock Liabilities rose 2420.88% to $228.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $228.8 million, marking a year-over-year increase of 2420.88%. This contributed to the annual value of $190.2 million for FY2024, which is 658.31% up from last year.
  • As of Q2 2025, Evolent Health's Preferred Stock Liabilities stood at $228.8 million, which was up 2420.88% from $193.2 million recorded in Q1 2025.
  • Evolent Health's Preferred Stock Liabilities' 5-year high stood at $228.8 million during Q2 2025, with a 5-year trough of $170.6 million in Q1 2023.
  • In the last 3 years, Evolent Health's Preferred Stock Liabilities had a median value of $182.8 million in 2024 and averaged $186.2 million.
  • Its Preferred Stock Liabilities has fluctuated over the past 5 years, first soared by 625.29% in 2024, then skyrocketed by 2420.88% in 2025.
  • Evolent Health's Preferred Stock Liabilities (Quarter) stood at $178.4 million in 2023, then rose by 6.58% to $190.2 million in 2024, then grew by 20.31% to $228.8 million in 2025.
  • Its Preferred Stock Liabilities stands at $228.8 million for Q2 2025, versus $193.2 million for Q1 2025 and $190.2 million for Q4 2024.